KSC Equity Snapshot
214390 Weekly Equity Report
Kyongbo Pharmaceutical Co., Ltd
What the company does
Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also provides medical devices, including portable X-ray machine and ultrasonic diagnostic equipment; and extraporeal shockwave therapy and temperature control PROBE. In addition, the company is involved in CDMO business; and research and development of Clopidogrel cardiovascular drug, Imatinlb anticancer drug, Donepezil anti-psychotic drug, Entecavir for anti-virus and infectious disease, and Esomeprazole. It also exports its products. The …
What the weekly tape is saying
214390 closed the latest completed week at 5,370 KRW. The 4-week return is -12.5% and the 12-week return is -24.9%. Trend Signal is inactive, Market Dynamics is -0.77. Setup signature: Risk-first tape with a 6/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 6,156 KRW
- Vs Trend Line
- -12.8%
- Fair Value
- 6,636 KRW
- Vs Fair Value
- -19.1%
- 52W High
- 9,300 KRW
- 52W Low
- 4,714 KRW
- Drawdown
- -42.3%
- Range Position
- 14.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 32
- 52W Active Breadth
- 61.5%
- Sector Scope
- KR Healthcare
- Sector Rank
- 35 of 63
- Sector Percentile
- 45.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 31 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 20 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.77
- 4W MD Change
- -656.8%
- Relative Strength
- -50.28
- 4W RS Change
- -18.4%
- Expectation
- Negative
- Probability
- 34.03%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 186.1K
- 13W Average
- 5.0M
- 52W Average
- 1.4M
- Vs 13W
- 0.0x
- Vs 52W
- 0.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.8%
- 52W Volatility
- 5.9%
- Upside Weeks
- 24
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 4.6% / -3.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 132.2B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 5,370 KRW | -0.6% | 6,156 KRW | 6,636 KRW | -0.77 | -50.28 | 186.1K | Off |
| 5 Jun 2026 | 5,400 KRW | -5.8% | 6,180 KRW | 6,646 KRW | -0.60 | -50.98 | 275.1K | Off |
| 29 May 2026 | 5,730 KRW | -8.5% | 6,211 KRW | 6,658 KRW | -0.36 | -50.81 | 317.9K | Off |
| 22 May 2026 | 6,260 KRW | 2.0% | 6,215 KRW | 6,669 KRW | -0.09 | -43.02 | 403.7K | On |
| 15 May 2026 | 6,140 KRW | -3.6% | 6,196 KRW | 6,675 KRW | 0.14 | -42.46 | 542.4K | On |
| 8 May 2026 | 6,370 KRW | -4.6% | 6,189 KRW | 6,681 KRW | 0.43 | -41.28 | 467.8K | On |
| 1 May 2026 | 6,680 KRW | -2.1% | 6,188 KRW | 6,685 KRW | 0.69 | -31.15 | 395.3K | On |
| 24 Apr 2026 | 6,820 KRW | -5.4% | 6,174 KRW | 6,688 KRW | 0.95 | -29.40 | 688.2K | On |
| 17 Apr 2026 | 7,210 KRW | 0.8% | 6,147 KRW | 6,685 KRW | 1.20 | -23.04 | 1.1M | On |
| 10 Apr 2026 | 7,150 KRW | -3.8% | 6,102 KRW | 6,682 KRW | 1.28 | -20.42 | 3.4M | On |
| 3 Apr 2026 | 7,430 KRW | -7.8% | 6,044 KRW | 6,682 KRW | 0.73 | -10.98 | 6.3M | On |
| 27 Mar 2026 | 8,060 KRW | 12.7% | 5,959 KRW | 6,677 KRW | 0.23 | -5.45 | 34.6M | On |
| 20 Mar 2026 | 7,150 KRW | 28.8% | 5,852 KRW | 6,666 KRW | -0.15 | -21.65 | 16.7M | On |
| 13 Mar 2026 | 5,550 KRW | -0.2% | 5,777 KRW | 6,660 KRW | -0.46 | -36.60 | 132.2K | Off |